Effective Oral Combination Treatment for Extended-Spectrum Beta-Lactamase-Producing <i>Escherichia coli</i>.

Al-Tamimi, Mohammad; Abu-Raideh, Jumana; Albalawi, Hadeel; Shalabi, Marwan; Saleh, Saiel

Effective Oral Combination Treatment for Extended-Spectrum Beta-Lactamase-Producing Escherichia coli.

Al-Tamimi, Mohammad; Abu-Raideh, Jumana; Albalawi, Hadeel; Shalabi, Marwan; Saleh, Saiel.

Affiliation

Al-Tamimi M; Department of Basic Medical Sciences, Faculty of Medicine, Hashemite University, Zarqa, Jordan.
Abu-Raideh J; Department of Basic Medical Sciences, Faculty of Medicine, Hashemite University, Zarqa, Jordan.
Albalawi H; Department of Basic Medical Sciences, Faculty of Medicine, Hashemite University, Zarqa, Jordan.
Shalabi M; Department of Pediatrics and Neonatology, Faculty of Medicine, Hashemite University, Zarqa, Jordan.
Saleh S; Department of Pediatrics and Neonatology, Faculty of Medicine, Hashemite University, Zarqa, Jordan.

Microb Drug Resist ; 25(8): 1132-1141, 2019 Oct.

Article de En | MEDLINE | ID: mdl-31107146

Sujet(s)
Mots clés

E. coli; cefixime; clavulanic acid; extended-spectrum beta-lactamase (ESBL); synergy

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Bêta-Lactamases / Association amoxicilline-clavulanate de potassium / Escherichia coli / Infections à Escherichia coli / Antibactériens Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Microb Drug Resist Sujet du journal: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Année: 2019 Type de document: Article Pays d'affiliation: Jordanie Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google